VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results - Reuters
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNTEZHNFNiQUJqVFpKbzgzNjlaNjNzSGRUdXh3QnlObmJqWXBWZ29IVkJmVmg5MUpoT1B6cERvWmZYUWU1TlIxSVkwblFiOGxYZjYtR0doZ0NZZ29JTHFIMUNDQVFzd29RSTRxQ0NuOWhsa3NtSTMwWk14dlhlLTVMakJqR2ZxUXN4YlRwMXhnTkg2dzB4eTN0NnFIMmY3MEVJOWNsVGxPMERja0cwTURmOVVxMlppbHNMSXBVUEFOUVRFZFVxZUs0?oc=5" target="_blank">VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Moderna shares surge as melanoma vaccine with Merck succeeds in large trial - reuters.com
Moderna shares surge as melanoma vaccine with Merck succeeds in large trial reuters.com
August 19, 2026 at 12:17 PMModerna shares double as cancer vaccine data rekindles investor hopes - Reuters
Moderna shares double as cancer vaccine data rekindles investor hopes Reuters
August 19, 2026 at 04:49 PMModerna, Merck breakthrough could usher in wave of cancer vaccines - Reuters
Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters
August 19, 2026 at 09:01 PMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMUS FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
August 13, 2026 at 09:33 PMCapricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026 at 10:41 AM